Improved Murine-MHC-Deficient HLA-Transgenic NOD-Mouse Models for Type 1 Diabetes Therapy Development

Diabetes - United States
doi 10.2337/db17-1467
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2017English

Transgenic Mouse Models for ADHD

Cell and Tissue Research
Forensic MedicinePathologyHistologyCell Biology
2013English

Conditional Analyses on the T1DGC MHC Dataset: Novel Associations With Type 1 Diabetes Around HLA-G and Confirmation of HLA-B

Genes and Immunity
ImmunologyGenetics
2008English

Functional Evidence for the Mediation of Diabetogenic T Cell Responses by HLA-A2.1 MHC Class I Molecules Through Transgenic Expression in NOD Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Adiponectin Receptor Fragmentation in Mouse Models of Type 1 and Type 2 Diabetes

2019English

A New Model for Dermatitis Herpetiformis That Uses HLA-DQ8 Transgenic NOD Mice

Journal of Clinical Investigation
Medicine
2004English

PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models

Cancer Research
Cancer ResearchOncology
2011English

Conditional Meta-Analysis Stratifying on Detailed HLA Genotypes Identifies a Novel Type 1 Diabetes Locus Around TCF19 in the MHC

Human Genetics
Genetics
2010English

Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy